UBS Group
IONS icon

UBS Group’s Ionis Pharmaceuticals IONS Stock Holding History

UBS Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-500
Closed -$24K – 7781
2016
Q4 		$24K Hold
500
– – ﹤0.01% 6399
2016
Q3 		$18K Sell
500
-90,000
-99% -$2.82M ﹤0.01% 6378
2016
Q2 		$2.11M Buy
90,500
+90,000
+18,000% +$2.9M ﹤0.01% 2738
2016
Q1 		$20K Sell
500
-2,000
-80% -$81.2K ﹤0.01% 6202
2015
Q4 		$155K Hold
2,500
– – ﹤0.01% 4872
2015
Q3 		$101K Sell
2,500
-100
-4% -$5.18K ﹤0.01% 5229
2015
Q2 		$150K Sell
2,600
-800
-24% -$50.9K ﹤0.01% 5107
2015
Q1 		$216K Sell
3,400
-6,900
-67% -$468K ﹤0.01% 4816
2014
Q4 		$636K Buy
+10,300
New +$508K ﹤0.01% 3975

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return